| Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication AN Antoniou, I Lenart, J Kriston-Vizi, T Iwawaki, M Turmaine, K McHugh, ... Annals of the rheumatic diseases 78 (1), 74-82, 2019 | 49 | 2019 |
| Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene S Ali, M Rivera, J Ward, E Keshavarz-Moore, C Mason, DN Nesbeth Heliyon 9 (6), 2023 | 1 | 2023 |
| Minimal impact of ZAP on lentiviral vector production and transduction efficiency H Sertkaya, L Hidalgo, M Ficarelli, D Kmiec, AW Signell, S Ali, H Parker, ... Molecular Therapy-Methods & Clinical Development 23, 147-157, 2021 | 1 | 2021 |
| Engineering an Autonucleolytic Mammalian Suspension Host Cell Line to Reduce DNA Impurity Levels in Serum-Free Lentiviral Process Streams G Howe, M Wasmuth, P Emanuelle, G Massaro, AA Rahim, S Ali, ... ACS Synthetic Biology, 2024 | | 2024 |
| DNA impurity reduction by a stably integrated staphylococcal nuclease is compatible with high-titer suspension serum-free rAAV manufacturing G Howe, M Bal, M Wasmuth, G Massaro, AA Rahim, S Ali, M Rivera, ... | | 2024 |
| Gene Editing/Gene Therapies: ENGINEERING HEK293T CELL LINES TO EXPRESS NUCLEASE FOR DNA CLEARANCE IN LENTIVIRAL VECTOR PRODUCTION S Ali, M Rivera, J Ward, E Keshavarz-Moore, C Mason, W Qasim, ... Cytotherapy 24 (5), S138, 2022 | | 2022 |
| Synthetic Biology Approach to Nucleic Acid Clearance in Lentiviral Vector Production S Ali, M Rivera, J Ward, E Keshavarz-Moore, C Mason, W Qasim, ... MOLECULAR THERAPY 30 (4), 62-62, 2022 | | 2022 |
| Synthetic Biology Approaches to Lentiviral Packaging Cell Engineering S Ali UCL (University College London), 2019 | | 2019 |
Darren N. NesbethAssociate Professor, Department of Biochemical Engineering, University College LondonVerified email at ucl.ac.uk
